Sensible Biotechnologies Raises $47 Million With In-Q-Tel Backing

Sensible Biotechnologies secured $47 million, with In-Q-Tel and OTB Ventures in a Series A plus up to $20 million from Slovakia and the EU, to scale its cell-based mRNA platform.